Literature DB >> 8719495

Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.

M R Mehra1, H O Ventura, F W Smart, D D Stapleton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719495

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  4 in total

1.  The 500 heart transplant.

Authors:  M R Mehra
Journal:  Ochsner J       Date:  2000-04

Review 2.  Update on pediatric heart transplantation. Long-term complications.

Authors:  R J Gajarski; D L Kearney; J K Price; S W Denfield
Journal:  Tex Heart Inst J       Date:  1997

Review 3.  Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators.

Authors:  Biagio Pietra; Mark Boucek
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

Authors:  Jon Kobashigawa
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.